60 related articles for article (PubMed ID: 38443675)
1. A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors.
Chen X; Liang W; Wu X; Wang Y; Hong Y; Xie M; Han R; Lin Z
Medicine (Baltimore); 2024 May; 103(19):e38017. PubMed ID: 38728499
[TBL] [Abstract][Full Text] [Related]
2. Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.
Liu A; Zhang G; Yang Y; Xia Y; Li W; Liu Y; Cui Q; Wang D; Yu J
Cancer Immunol Immunother; 2024 Jun; 73(8):152. PubMed ID: 38833153
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma.
Zhao JD; Lu XY; Chen TP; Duan XL; Zuo W; Sai K; Zhu LR; Gao Q
Eur J Surg Oncol; 2024 Jun; 50(6):108321. PubMed ID: 38598875
[TBL] [Abstract][Full Text] [Related]
4. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
Jiang T; Sun H; Xu T; Xue S; Xia W; Xiao X; Wang Y; Guo L; Lin H
J Inflamm Res; 2024; 17():3353-3369. PubMed ID: 38803689
[TBL] [Abstract][Full Text] [Related]
5. A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1.
He M; Liang C; Pang Y; Jiang M; Long M; Yao Z; Wang X; Zhang R; Wu Q; Liang S; Li J
J Hepatocell Carcinoma; 2024; 11():913-925. PubMed ID: 38799002
[TBL] [Abstract][Full Text] [Related]
6. A novel nomogram based on inflammation biomarkers for predicting radiation cystitis in patients with local advanced cervical cancer.
Lin J; Lin J; Liu L; Xie N; Yu H; Deng S; Sun Y
Cancer Med; 2024 May; 13(10):e7245. PubMed ID: 38785171
[TBL] [Abstract][Full Text] [Related]
7. Novel prediction model combining PET/CT metabolic parameters, inflammation markers, and TNM stage: prospects for personalizing prognosis in nasopharyngeal carcinoma.
Liang H; Tan W; Wang J; Li M; Pang H; Wang X; Yang L; Jing X
Ann Nucl Med; 2024 Jun; ():. PubMed ID: 38874876
[TBL] [Abstract][Full Text] [Related]
8. Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis.
Weng KG; Lei HK; Shen DS; Wang Y; Zhu XD
Cancer Manag Res; 2024; 16():603-616. PubMed ID: 38855327
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer.
Xu Y; Li H; Wang X; Li B; Gao A; Zhao Q; Yang L; Qin W; Wang L
J Inflamm Res; 2024; 17():3671-3683. PubMed ID: 38867842
[TBL] [Abstract][Full Text] [Related]
10. Comment on "Evaluation and validation of neutrophil to albumin ratio as a promising prognostic marker for all-cause mortality in patients with cancer: A multicenter cohort study".
Fu M
Nutrition; 2024 Aug; 124():112445. PubMed ID: 38735201
[No Abstract] [Full Text] [Related]
11. The prognostic value of preoperative neoindices consisting of lymphocytes, neutrophils and albumin (LANR) in operable breast cancer: a retrospective study.
Wang Y; Zhuang J; Wang S; Wu Y; Chen L
PeerJ; 2024; 12():e17382. PubMed ID: 38766483
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
[TBL] [Abstract][Full Text] [Related]
13. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
14. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
15. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
[TBL] [Abstract][Full Text] [Related]
16. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
[TBL] [Abstract][Full Text] [Related]
17. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
